ATE423106T1 - Verfahren zur kristallisation von n-(1(s)- ethoxycarbonyl-3-phenylpropyl)-l-alanin n- carbonsäureanhydrid - Google Patents

Verfahren zur kristallisation von n-(1(s)- ethoxycarbonyl-3-phenylpropyl)-l-alanin n- carbonsäureanhydrid

Info

Publication number
ATE423106T1
ATE423106T1 AT01930174T AT01930174T ATE423106T1 AT E423106 T1 ATE423106 T1 AT E423106T1 AT 01930174 T AT01930174 T AT 01930174T AT 01930174 T AT01930174 T AT 01930174T AT E423106 T1 ATE423106 T1 AT E423106T1
Authority
AT
Austria
Prior art keywords
phenylpropyl
ethoxycarbonyl
alanine
crystallization
acid anhydride
Prior art date
Application number
AT01930174T
Other languages
English (en)
Inventor
Masafumi Fukae
Yasuyoshi Ueda
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Application granted granted Critical
Publication of ATE423106T1 publication Critical patent/ATE423106T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44Two oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
AT01930174T 2000-05-15 2001-05-15 Verfahren zur kristallisation von n-(1(s)- ethoxycarbonyl-3-phenylpropyl)-l-alanin n- carbonsäureanhydrid ATE423106T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000141717 2000-05-15
JP2000330339 2000-10-30
JP2000352892 2000-11-20

Publications (1)

Publication Number Publication Date
ATE423106T1 true ATE423106T1 (de) 2009-03-15

Family

ID=27343377

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01930174T ATE423106T1 (de) 2000-05-15 2001-05-15 Verfahren zur kristallisation von n-(1(s)- ethoxycarbonyl-3-phenylpropyl)-l-alanin n- carbonsäureanhydrid

Country Status (17)

Country Link
US (1) US6784310B2 (de)
EP (1) EP1283204B1 (de)
JP (1) JP4149706B2 (de)
KR (1) KR100527648B1 (de)
CN (1) CN1184213C (de)
AT (1) ATE423106T1 (de)
AU (1) AU5675801A (de)
CZ (1) CZ2002532A3 (de)
DE (1) DE60137686D1 (de)
ES (1) ES2320413T3 (de)
HR (1) HRP20020122A2 (de)
HU (1) HUP0202516A3 (de)
IS (1) IS6224A (de)
PL (1) PL351841A1 (de)
SI (1) SI20817A (de)
TW (1) TW527351B (de)
WO (1) WO2001087858A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100487029C (zh) 2003-08-29 2009-05-13 积水化成品工业株式会社 聚烯烃系树脂改性的聚苯乙烯系树脂的预发泡粒子及其制备方法和发泡成形体
JP4852282B2 (ja) * 2005-08-29 2012-01-11 保土谷化学工業株式会社 N−カルボン酸無水物の製造方法
CN101293887A (zh) * 2007-04-26 2008-10-29 中国科学院福建物质结构研究所 一种高纯度环状硫酸酯的纯化方法
JP2011016790A (ja) 2009-06-08 2011-01-27 Sumitomo Chemical Co Ltd ピラゾリノン誘導体の精製方法
WO2014202659A1 (en) 2013-06-21 2014-12-24 Sanofi-Aventis Deutschland Gmbh Process for the preparation of amides of n-[1-(s)-(ethoxycarbonyl)-3-phenylpropyl]-l-alanine
WO2020064904A1 (en) 2018-09-28 2020-04-02 Lonza Ltd Method for preparation of n-carboxyanhydrides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496542A (en) 1981-03-30 1985-01-29 Usv Pharmaceutical Corporation N-substituted-amido-amino acids
US4831184A (en) * 1981-03-30 1989-05-16 Rorer Pharmaceutical Corporation N-substituted-amido-amino acids
JPS6248696A (ja) 1985-08-27 1987-03-03 Kanegafuchi Chem Ind Co Ltd N−〔1(s)−エトキシカルボニル−3−フエニルプロピル〕−l−アラニル−l−プロリンの製造法
SI9200213A (en) 1992-09-16 1994-03-31 Krka Process for preparing alkyl-l-alanil-l-proline derivates
EP0668859B1 (de) 1992-11-13 1997-02-26 E.I. Du Pont De Nemours And Company Verfahren zur herstellung von 2,4-oxazolidinedionen
IN184759B (de) * 1997-07-22 2000-09-23 Kaneka Corp
JP4505917B2 (ja) 1999-01-22 2010-07-21 田辺三菱製薬株式会社 新規微生物およびそれを用いるl−アミノ酸の製法

Also Published As

Publication number Publication date
HUP0202516A3 (en) 2003-04-28
HUP0202516A2 (hu) 2003-01-28
HRP20020122A2 (en) 2003-04-30
PL351841A1 (en) 2003-06-16
CZ2002532A3 (cs) 2002-05-15
EP1283204A4 (de) 2007-09-05
KR20020038689A (ko) 2002-05-23
WO2001087858A1 (en) 2001-11-22
AU5675801A (en) 2001-11-26
KR100527648B1 (ko) 2005-11-09
SI20817A (sl) 2002-08-31
EP1283204A1 (de) 2003-02-12
CN1380881A (zh) 2002-11-20
EP1283204B1 (de) 2009-02-18
DE60137686D1 (de) 2009-04-02
JP4149706B2 (ja) 2008-09-17
IS6224A (is) 2002-01-09
TW527351B (en) 2003-04-11
US6784310B2 (en) 2004-08-31
ES2320413T3 (es) 2009-05-22
US20020137944A1 (en) 2002-09-26
CN1184213C (zh) 2005-01-12

Similar Documents

Publication Publication Date Title
DE60030877D1 (de) Nichtkorrosive reinigungszusammensetzung zur entfernung von plasmaätzrückständen
DK0783486T3 (da) Hidtil ukendte prostaglandinsynthaseinhibitorer
BG103694A (bg) Метод за получаване и пречистване на n- алкилирано аспарагиново производно
ATE461270T1 (de) Verfahren zur herstellung von l-aminosäuren
HK1049165A1 (zh) 循环β-氨基酸衍生物作为质基金属蛋白酶及TNF-α的抑制剂
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
NO20044406L (no) Stabilisert flytende farmasoytisk sammensetning samt fremgangsmate for a oke stabiliteten av IL-2
DE502004004307D1 (de) Verfahren zur herstellung von gereinigten 1,3-substituierten imidazoliumsalzen
DE60312033D1 (de) Verfahren zur verringerung der bitterkeit von aminosäure
ATE423106T1 (de) Verfahren zur kristallisation von n-(1(s)- ethoxycarbonyl-3-phenylpropyl)-l-alanin n- carbonsäureanhydrid
DE60326007D1 (de) Inhibierung der kristallisation von kolophonium
DE69205623D1 (de) Verfahren zur Herstellung von Amid durch Oximumlagerung in flüssiger Phase.
ATE248806T1 (de) N-3, 3-dimethylbutyl-l-asparaginsäure und ihre ester, verfahren zur herstellung dieser und das verfahren um daraus n-(n-(3,3-dimethylbutyl)-l- alpha-aspartyl)-l-phenylalanin-1-methylester herzustellen
DE50107209D1 (de) Verfahren zur herstellung von 5-aminosalicylsäure
DE69523038D1 (de) Verfahren zur herstellung von hiv proteasinhibitoren
DE50107377D1 (de) Verfahren zur herstellung von 2-alkyl-3-aryl- und -heteroaryloxaziridinen und neue 2-alkyl-3-aryloxaziridine
DE69521887D1 (de) Verbessertes verfahren zur herstellung von 6,9[(zaminoethyl)amino]benzo[g]isochinoline-5,10 dione und sein dimaleinsaeure salz
ATE271551T1 (de) Verfahren zur herstellung von n-(1-(s)- ethoxycarbonyl-3-phenylpropyl)-l-alanin-n- carboxyanhydrid
DE60013326D1 (de) Verbindungen und verfahren zur behandlung von schmerz
CA2414936A1 (en) Thiophene retinoids
ATE296311T1 (de) Verfahren zur herstellung pharmakologisch verträglicher salze von n-(1(s)-ethoxycarbonyl-3- phenylpropyl)-l-alanyl aminosäuren
DE69901792D1 (de) Verfahren zur herstellung von 2-acetylthio-3-phenyl-propionsäure und deren salzen
ATE327218T1 (de) Verfahren zur herstellung von 1-methyl-3- nitroguanidin
ATE288445T1 (de) Herstellung von n-(n-(3,3-dimethylbutyl)-l-alpha- aspartyl)-l-phenylalanin-1-methylester durch verwendung vom l-alpha-aspartyl-l-phenylalanin-1- methylester als vorläufer
ATE348840T1 (de) Verfahren zur prävention einer durch gefrieren induzierten abnahme der aktivität eines proteins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1283204

Country of ref document: EP